SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunex -- Ignore unavailable to you. Want to Upgrade?


To: twt who wrote (398)3/5/2000 11:29:00 AM
From: KB  Respond to of 656
 
With the sector white-hot, the positive press and hype of a 'next generation', 'side-effect-free' treatment for something as common as asthma will blow IMNX above $350.



To: twt who wrote (398)3/5/2000 8:54:00 PM
From: LemurHouse  Respond to of 656
 
Nuvance will be huge. I didn't realize that they would be announcing phase III results as early as this summer. Valuation here is already pretty rich, but I agree that the Nuvance news should power the stock even further this week.